Amygdala Neuroscience Competitors and Similar CompaniesClear all
Amygdala Neuroscience's competitors and similar companies include GBT (Global Blood Therapeutics), Travere Therapeutics, United Biomedical and Curza.
 Amygdala Neuroscience Amygdala Neuroscience is a company that develops therapies designed to cure addiction. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |  Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. |  United Biomedical United Biomedical is a biopharmaceutical company dedicated to the discovery, development, and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. |  Curza Curza Global is a small-molecule therapeutics company that develops drugs for infectious diseases and oncology. | |
Founding Date | Founding Date 2015 | Founding Date 2012 | Founding Date 2011 | Founding Date 1985 | Founding Date 2021 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations HQ | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations San Diego, US HQ Dublin, IE | Locations Salt Lake City, US HQ | |
Employees | Employees N/A | Employees 352106% increase | Employees 46293% increase | Employees 45 | Employees 186% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.4 b | Valuation ($) 1.4 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) $490.7m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $3.3m (FY, 2021) | Cost of goods $10.3m (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Net income | Net income N/A | Net income ($303.1m) (FY, 2021) | Net income ($25.5m) (FY, 2025) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 7m | Total funding raised $ 88.7m | Total funding raised $ 25m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyTravere Therapeutics
HQ
San Diego, US
Employees
462
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View companyUnited Biomedical
HQ
Hauppauge, US
Employees
45
United Biomedical is a biopharmaceutical company dedicated to the discovery, development, and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases.
View companyCurza
HQ
Salt Lake City, US
Employees
18↑ 6% increase
Curza Global is a small-molecule therapeutics company that develops drugs for infectious diseases and oncology.
View company